News

EMD Serono Healthcare Business

EMD Serono Healthcare Business

Chris Round, President of EMD Serono, the healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada discusses what’s next for the company; his experience leading the business in four international markets and how it helped prepare him for his current role leading the U.S. business; fertility solutions that have helped mothers conceive and birth more than 3 million babies globally; and infusing healthcare professional, patient, and caregiver voices into EMD Serono programs and collaborations. 

Frequently Asked Questions

What is the main topic discussed in this episode of Health Professional Radio?

This episode covers important developments in healthcare, including updates on Healthcare. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.

How can healthcare professionals benefit from this information?

Healthcare professionals can stay informed about the latest developments in Healthcare and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.

Where can I find more information about Healthcare?

For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.

Chris Round is President of EMD Serono, leading the North American healthcare business across the U.S. and Canada

Chris is a recognized leader in the pharmaceutical industry with a wealth of strategic and operational achievements. His track record includes launch experience, business transformation from primary care to oncology, leadership of local and regional operations, as well as global responsibilities in executive leadership teams. Chris has been with the organization since 2017, previously serving as Head of International and Core Franchises, where he was responsible for our international business comprised of China, Asia Pacific, Europe, Middle East, Africa, Russia and Latin America, and also had global accountability for the Fertility and the Cardiovascular Metabolism & Endocrinology (CM&E) Franchises.

Chris brings 25 years of global pharmaceutical experience to this position, including 20 years at Merck & Co., Inc. Chris started his professional career in finance with PwC in the UK. He holds a BA in Economics and Accounting from Newcastle University in the United Kingdom.

Last updated: June 24, 2022

Medical Disclaimer

The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.